Table 1 Baseline clinical characteristics in patients with and without VDRA therapy
Clinical characteristic | Total | VDRA | P-value | |
|---|---|---|---|---|
Yes | No | |||
General | ||||
N (%) | 568 | 389 (68.5) | 179 (31.5) | |
Gender (male), n (%) | 389 (68.5) | 260 (66.9) | 129 (72.1) | |
Median age (IQR), years | 70 (57–77) | 69 (56–76.5) | 70 (60–77) | 0.31 |
Median height (IQR), cn | 165 (160–170) | 165 (160–171) | 167 (160–170) | 0.89 |
BMI (Kg/M2) | 23.5 (21.2-26.4) | 23.5 (21.2-26.3) | 23.4 (20.8-26.5) | 0.47 |
Comorbid diseases | ||||
Hypertension, n (%) | 496 (87.3) | 347 (89.2) | 149 (83.2) | 0.05 |
Cardiovascular disease, n (%) | 338 (59.5) | 233 (59.9) | 105 (58.7) | 0.78 |
Vascular disease, n (%) | 277 (48.8) | 188 (48.3) | 89 (49.7) | 0.6 |
Diabetes, n (%) | 164 (28.9) | 109 (28) | 55 (30.7) | 0.52 |
Dyslipidemia, n (%) | 104 (18.3) | 164 (42.2) | 61 (34.1) | 0.07 |
Liver disease, n (%) | 54 (9.5) | 42 (10.8) | 12 (6.7) | 0.12 |